Soratinex Emollient – 50g
For Psoriasis Prone Skin
- Removes dead skin cells
- Soothes itchy skin
- Reduces redness and irritation
- Repairs skin barrier
- Dermatologically Tested
For
- Very Dry Skin
- Thickened, Scaly Skin
- Itchy Skin
- Soothing and calming
- Moisturising and hydrating
- Restoring essential skin lipids
Soratinex Emollient was designed specifically with psoriasis skin in mind. It is jam-packed with over 18 natural active ingredients designed to deliver nourishing oils and protective antioxidants to where it is needed most. It is best suited for thick, dry, and flaky skin of the scalp and body in adults.
Extra tip: Applying the Soratinex Skin Care Oil on top of the Emollient helps to provide a “lock and seal” effect, which locks in hydration from the Emollient for longer-lasting effects.
Ingredients: Paraffinum solidum, Solanum tuberosum, Paraffinum liquidum, Zinc Oxide, Salicylic Acid, Prunus Amygdalus dulcis oil, Simmondsia chinensis oil, Persea gratissima oil, Daucus carota oil, Calendula officinalis extract, Aurantii dulcis, Triticum vulgare germ oil, Prunus armeniaca kernel oil, Lavandula augustifolia oil, Santalum album oil, Pogostemon cablin oil, Pelargonium graveolens, Rosmarinus offinalis extract, Dromiceius oil, Oenothera biennis oil, Eucalyptus globulus oil, Pinus sylvestris leaf oil, Chamomilla recutita oil, Commiphora myrrha oil, Citrus aurantium amara flower oil.
Michael Tirant Pharmaceuticals
Professor Tirant scientifically researched and formulated a range of clinical preparations under the name of Dr. Michaels for the treatment of various skin conditions. Dr. Michael’s products are for clinical use only and are often customised to a person’s individual needs. Dr. Michael’s products have a 30-year history of successful clinical use for the relief of different skin conditions.
The Soratinex product range was developed for people with mild to moderate skin conditions, based on key active ingredients in the Dr. Michaels range. Soratinex works via a dual action by way of oral and topical products that reduce inflammation and encourage skin repair.
In 2013 the Soratinex product range received EU cosmetic registration approval, and in 2016 Soratinex became a registered medical device.
Soratinex products have been dermatologically tested and approved.
The products have undergone skin sensitisation, skin irritation, eye irritation, and bacteria mutation testing as well as stability testing and a safety assessment.
In order to produce the Soratinex range MT Dermaceuticals has partnered with leading manufacturers who are GMP-registered and licensed to manufacture therapeutic goods under TGA registration.
